Lilly to Address Humulin R U-500 Insulin Errors

Eli Lilly U-500 Insulin

| Apr 28, 2014

Insulin prescription errors rank first among all prescribed drugs. In an effort to remedy this problem, Eli Lilly is developing a prefilled pen for delivering Humulin R U-500 insulin as well as collaborating on the development of a dedicated U-500 syringe.

This news comes from the Institute for Safe Medication Practices, which says that errors involving U-500 are a major cause for insulin's number-one ranking among misprescribed drugs. The concern is that because U-500 is a much more concentrated form of insulin than the more commonly prescribed U-100, misprescribing it can have serious consequences. The drug is prescribed for patients who have become extremely insulin-resistant and therefore need more concentrated amounts of insulin per dose than patients who use U-100.

The problem with the drug arises in two areas:

1. Unfamiliarity among prescribers with the differences between the two insulins, opening the door to potential prescription mistakes.

2. U-500 has to be administered using a U-100 syringe or a volumetric syringe; however, U-500 is concentrated differently from U-100 and so the U-100 syringe unit markings can be misleading and inappropriate.

The ISMP says that one problem with misprescribing U-500 often lies in prescribers' computer setups. U-500 and U-100 may be only one line apart on a screen, making it easy for prescribers to click on the wrong choice once they see the line "Humulin R Injection Solution." This is especially likely if the prescriber's computer screen does not make other essential information, such as "100 UNITS/ML" or "500 UNITS/ML," visible in the same line.

Among the steps ISMP recommends prescribers take to avoid confusing the two insulins are:

• List U-500 apart from other insulins, in its own distinct category, so that it is not confused with U-100.

• Place a hard stop after all U-500 prescriptions that forces prescribers and pharmacists to confirm that a patient requires a concentrated strength insulin.

• If prescribers have no patients who require U-500, simply do not list the insulin in their databases to completely avoid the possibility of a prescription error.

While Lilly is working on creating delivery devices that will eliminate much of the problem, it cannot say when the devices might be available. Aside from research and development, the devices will have to gain regulatory approval, a process whose length nobody can predict.

Click Here To View Or Post Comments


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (1)

You May Also Be Interested In...


Posted by Anonymous on 27 August 2014

As a U-500 insulin user, I would greatly appreciate the implementation of pre-filled pens for this medication. I fail to understand why, since this is a concentrated insulin, it isn't available in 100ml vials. We are instructed to discard our U-500 vial after 28 days, and we are literally throwing away about half the bottles contents, which is a total waste, both for money and insulin.

It's just odd that the non-concentrated version (which requires multiple vials for a month's worth of insulin) is offered in smaller quantities, yet the concentrated version is only offered in a vial where half of the contents are wasted and thrown away. Where is the logic in this?

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.